SCHEMBL8607883

SCHEMBL8607883

N[O-].N[O-].N[O-].N[O-].[Os+4]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL414817 0.75
SCHEMBL5697730 0.75
Silver SCHEMBL3403893 0.75
SCHEMBL9418837 0.75
SCHEMBL7638046 0.75
SCHEMBL6473537 0.75
Zinc Ion SCHEMBL2301994 0.75
SCHEMBL5570597 0.75
SCHEMBL5554618 0.75
SCHEMBL8072862 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5792607-A SPECIFIC HYBRIDIZATION OF PROBE/PRIMER END SO THAT THE PROBABILITY OF THE PROBE/PRIMER CONTRIBUTING TO SPURIOUS SIGNAL DEVELOPMENT IS GREATLY REDUCED ABBOTT LABORATORIES (US) 1998-08-11 US disclosed
EP-0439182-B1 Improved method of amplifying target nucleic acids applicable to both polymerase and ligase chain reactions ABBOTT LAB (US) 1996-04-24 EP disclosed
WO-1995011300-A2 AZOOSPERMIA IDENTIFICATION AND TREATMENT MEDICAL RESEARCH COUNCIL (GB) 1995-04-27 WO disclosed
EP-0439182-A2 Improved method of amplifying target nucleic acids applicable to both polymerase and ligase chain reactions ABBOTT LABORATORIES (US) 1991-07-31 EP disclosed